| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 5.254 | 6.990 | 42.546 | 235.992 | 379.188 | 454.683 | 369.398 |
| Total Income - EUR | - | - | - | 5.254 | 6.990 | 42.585 | 238.042 | 380.439 | 464.332 | 404.728 |
| Total Expenses - EUR | - | - | - | 84 | 6.234 | 4.863 | 30.275 | 72.545 | 141.961 | 115.906 |
| Gross Profit/Loss - EUR | - | - | - | 5.170 | 755 | 37.721 | 207.766 | 307.895 | 322.371 | 288.822 |
| Net Profit/Loss - EUR | - | - | - | 5.012 | 546 | 37.255 | 206.032 | 304.166 | 318.714 | 276.923 |
| Employees | - | - | - | 0 | 0 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Bodea Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 626 | 2.254 | 8.390 | 70.037 | 62.859 | 55.282 |
| Current Assets | - | - | - | 5.297 | 370 | 39.407 | 225.403 | 257.694 | 374.914 | 734.017 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 75.081 |
| Receivables | - | - | - | 1.504 | 0 | 0 | 35 | 208.741 | 0 | 222.644 |
| Cash | - | - | - | 3.793 | 370 | 39.407 | 225.368 | 48.954 | 374.914 | 436.293 |
| Shareholders Funds | - | - | - | 5.055 | 596 | 37.840 | 231.541 | 304.215 | 416.285 | 276.971 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 242 | 400 | 1.821 | 2.252 | 23.516 | 21.488 | 512.327 |
| Income in Advance | - | - | - | 0 | 0 | 2.001 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Bodea Med S.r.l.